Profil Institute lands new alliance focused on metabolic disease
CRO Profil Institute for Clinical Research will collaborate with Denmark-based Gubra ApS, a metabolic preclinical and drug discovery company, to discover and translate into clinical research novel drug targets, compounds and biomarkers addressing...